These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9201177)

  • 21. Basal cell carcinomata: Risk factors for incomplete excision and results of re-excision.
    Masud D; Moustaki M; Staruch R; Dheansa B
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):652-6. PubMed ID: 26948998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer.
    Chiller K; Passaro D; McCalmont T; Vin-Christian K
    Arch Dermatol; 2000 Nov; 136(11):1327-32. PubMed ID: 11074693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperspectral imaging system in the delineation of Ill-defined basal cell carcinomas: a pilot study.
    Salmivuori M; Neittaanmäki N; Pölönen I; Jeskanen L; Snellman E; Grönroos M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):71-78. PubMed ID: 29846972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
    van Kester MS; Goeman JJ; Genders RE
    J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-risk basal cell carcinoma excision in primary care: a retrospective observational study of compliance with NICE guidance.
    Cole SJ; Howes R; Meehan C; Cole R
    BMJ Open; 2019 Feb; 8(11):e023299. PubMed ID: 30798290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of margin detection by digital dermoscopy in the traditional surgical excision of basal cell carcinomas of the head and neck including infiltrative/morpheaform type.
    Carducci M; Bozzetti M; De Marco G; Foscolo AM; Betti R
    J Dermatol; 2012 Apr; 39(4):326-30. PubMed ID: 22150641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma.
    Roozeboom MH; Mosterd K; Winnepenninckx VJ; Nelemans PJ; Kelleners-Smeets NW
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):894-8. PubMed ID: 22691131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
    Hansen C; Wilkinson D; Hansen M; Soyer HP
    Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small margin excision of periocular basal cell carcinomas.
    Chadha V; Wright M
    Br J Ophthalmol; 2009 Jun; 93(6):803-6. PubMed ID: 19304655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
    Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
    Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
    Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
    Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The significance of incomplete excision in patients with basal cell carcinoma.
    Richmond JD; Davie RM
    Br J Plast Surg; 1987 Jan; 40(1):63-7. PubMed ID: 3814899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper?
    Griffiths RW; Suvarna SK; Stone J
    J Plast Reconstr Aesthet Surg; 2007; 60(1):41-7. PubMed ID: 17126265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of 110 basal cell carcinomas of the eyelid treated with frozen section-controlled excision: mean follow-up over 5 years.
    Giordano Resti A; Sacconi R; Baccelli N; Bandello F
    Eur J Ophthalmol; 2014; 24(4):476-82. PubMed ID: 24338583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision.
    Silverman MK; Kopf AW; Bart RS; Grin CM; Levenstein MS
    J Dermatol Surg Oncol; 1992 Jun; 18(6):471-6. PubMed ID: 1592998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
    Bartoš V; Kullová M
    Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathological variation of incompletely excised basal cell carcinoma's and the variation with the grade of surgeon - implications for revalidation.
    Robinson AJ; Walsh M; Hill C
    Eur J Surg Oncol; 2015 Jan; 41(1):165-8. PubMed ID: 25468457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.